Navigation Links
New Dermatological Formula Targets Psoriasis, Eczema and Other Extreme Skin Conditions

ORMOND BEACH, Fla., Sept. 13, 2011 /PRNewswire/ -- Florida-based SkinHealth Technology introduces a powerful, breakthrough formula that combines cutting-edge cosmeceutical ingredients -- peptides, polysaccharides and botanical emollients -- with a proven skin protectant to help combat even the most serious skin conditions. ExtremeSkinCare Intense Treatment Balm helps reduce the unsightly appearance of psoriasis, eczema, and rosacea and relieve inflamed and irritated skin without steroids.

Millions of Americans are affected by psoriasis, eczema, rosacea or other troublesome skin conditions, leaving them searching for a safe, effective topical treatment.

Dermatologist Jeffrey Parks, MD and a team of skincare experts have developed a formulation containing a perfect combination of ingredients that help reduce inflammation, redness and clear affected skin of plaques.

ExtremeSkinCare Intense Treatment Balm:

  • Helps reduce inflammation, redness, itching and irritation
  • Protects and relieves dry, cracked and scaling skin
  • Increases skin's resistance to further physical damage by 60%
  • Helps improve skin elasticity and stimulates collagen synthesis

SkinHealth Technology LLC, an R&D based development company which formulates advanced dermatological, therapeutic skincare products, was founded in 2008. Jeffrey Parks, MD and a team of skincare professionals develop effective formulas that address bruising, acne, vitamin D deficiency, sun damage and chronic skin conditions.

For more detailed information about ExtremeSkinCare Intense Treatment Balm or to schedule an interview, please contact Jack Surrette at 386.236.9949 or visit


Jack Surrette
Executive Director
SkinHealth Technology LLC
P.O. Box 731626, Ormond Beach, FL 32173
386.236.9949 or

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at

SOURCE SkinHealth Technology LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBays Novel Aganocide Drugs for Major Dermatological Conditions
2. Pradaxa® (dabigatran etexilate mesylate) Capsules Now on Formulary at Nations Top Heart Hospitals
3. BioLife Solutions Now The Leading Supplier of Pre-Formulated GMP Cryopreservation Media for Umbilical Cord Blood Stem Cells
4. Cerno Bioscience Introduces MassWorks AutoID for Fully Automated Quadrupole MS Formula Determination
5. Parenteral Depots Offer $8 Billion of Reformulation Opportunities and a Strong Competitive Edge in Crowded Pharmaceutical Space
6. Advanced Life Sciences Submits Full Proposal to NIAID for Development of Intravenous Formulation of Restanza as a Biodefense Countermeasure
7. Kibow Biotech Releases Results of Pilot Scale Study of Its Probiotic Formulation for Kidney Health
8. Australian Patent Issued to CreAgri® for Ultraviolet Radiation (UVR) Protection by its Hydroxytyrosol-Based Formulations
9. Biosynthetic corneas formulated with recombinant collagen restore vision and nerve growth
10. Advanced Life Sciences Announces Successful Preclinical Data Supporting Restanza Intravenous Formulation for Hospital Use
11. Maximize Market Research to Improve Formulary Access Within Managed Markets Sector
Post Your Comments:
(Date:11/25/2015)... November 25, 2015 Studies reveal ... human plaque and pave the way for more effective treatment ... cats     --> ... diagnosed health problems in cats, yet relatively little was understood ... collaborative studies have been conducted by researchers from the WALTHAM ...
(Date:11/25/2015)... Nov. 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... in a fireside chat discussion at the Piper Jaffray ... . The discussion is scheduled for Wednesday, December ... .  A replay will be available for 14 ... , Julie NormartVP, Corporate Communications and Business Development ...
(Date:11/24/2015)... -- Cepheid (NASDAQ: CPHD ) today announced that ... and invited investors to participate via webcast. ... 1, 2015 at 11.00 a.m. Eastern Time --> ... 1, 2015 at 11.00 a.m. Eastern Time --> ... NY      Tuesday, December 1, 2015 at 11.00 ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the ... the Toronto Stock Exchange, confirms that as of the ... developments that would cause the recent movements in the ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged in ...
Breaking Biology Technology:
(Date:10/29/2015)... NXTD ) ("NXT-ID" or ... the growing mobile commerce market and creator of ... leading marketplace to discover and buy innovative technology ... on StackSocial for this holiday season.   ... a biometric authentication company focused on the growing ...
(Date:10/27/2015)... , Oct. 27, 2015 Synaptics Inc. (NASDAQ: ... announced that Google has adopted the Synaptics ® ... solutions to power its newest flagship smartphones, the Nexus ... --> --> ... to provide strategic collaboration in the joint development of ...
(Date:10/23/2015)... 23, 2015 Research and Markets ( ... Voice Recognition Biometrics Market 2015-2019" report to their ... The global voice recognition biometrics market to grow ... --> --> The report, ... based on an in-depth market analysis with inputs from ...
Breaking Biology News(10 mins):